Jun 13, 2018

FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

Posted by in category: neuroscience

Good news: The toolkit for neurorehabilitation is growing.

___ MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release): MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion™ GO, in the United States. Together with.

Read more

Comments are closed.